SCHEMBL2446274

SCHEMBL2446274

COc1cc(Cl)cc(C=NO)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.63
L3MBTL1 Q9Y468 3/20 0.48
ERN1 O75460 1/20 0.47
HPGD P15428 4/20 0.46
TSHR P16473 3/20 0.46
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 3/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP3A4 P08684 4/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 6/20 0.43
MEN1 O00255 5/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
HTT P42858 2/20 0.43
MAPT P10636 3/20 0.42
LMNA P02545 2/20 0.42
CYP2D6 P10635 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2446271 1.00 GAA (0.63) GAAL3MBTL1ERN1HPGDTSHR
SCHEMBL2448486 0.84 GAA (0.53) GAAL3MBTL1ERN1HPGDTSHR
SCHEMBL2448485 0.84 GAA (0.53) GAAL3MBTL1ERN1HPGDTSHR
SCHEMBL30393930 0.81 ALDH1A1 (0.52) GAAHPGDALDH1A1HSD17B10CYP3A4
Hydrochloric Acid SCHEMBL5703117 0.79 GRIN2D (0.55) GAAL3MBTL1ALDH1A1KDM4ENPC1
SCHEMBL24495458 0.77 HPGD (0.69) GAAL3MBTL1HPGDTSHRALDH1A1
SCHEMBL2447953 0.77 HPGD (0.69) GAAL3MBTL1HPGDTSHRALDH1A1
SCHEMBL29687081 0.77 HPGD (0.69) GAAL3MBTL1HPGDTSHRALDH1A1
SCHEMBL2447956 0.77 HPGD (0.69) GAAL3MBTL1HPGDTSHRALDH1A1
SCHEMBL1748175 0.77 ERN1 (0.66) GAAL3MBTL1ERN1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed
CN-101316852-A Inhibitors of serine proteases VERTEX PHARMA (US) 2008-12-03 CN disclosed